JPWO2020005819A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020005819A5 JPWO2020005819A5 JP2020567827A JP2020567827A JPWO2020005819A5 JP WO2020005819 A5 JPWO2020005819 A5 JP WO2020005819A5 JP 2020567827 A JP2020567827 A JP 2020567827A JP 2020567827 A JP2020567827 A JP 2020567827A JP WO2020005819 A5 JPWO2020005819 A5 JP WO2020005819A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- residue
- polypeptide
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 96
- 102000004196 processed proteins & peptides Human genes 0.000 claims 54
- 229920001184 polypeptide Polymers 0.000 claims 51
- 125000003275 alpha amino acid group Chemical group 0.000 claims 41
- 108090000623 proteins and genes Proteins 0.000 claims 18
- 102000004169 proteins and genes Human genes 0.000 claims 15
- -1 CAMPATH-1 Chemical compound 0.000 claims 14
- 235000018102 proteins Nutrition 0.000 claims 14
- 206010028980 Neoplasm Diseases 0.000 claims 10
- 235000001014 amino acid Nutrition 0.000 claims 10
- 239000000833 heterodimer Substances 0.000 claims 10
- 102000010789 Interleukin-2 Receptors Human genes 0.000 claims 9
- 210000004027 cell Anatomy 0.000 claims 9
- 108010038453 Interleukin-2 Receptors Proteins 0.000 claims 8
- 101000628535 Homo sapiens Metalloreductase STEAP2 Proteins 0.000 claims 6
- 102100026711 Metalloreductase STEAP2 Human genes 0.000 claims 6
- 102000039446 nucleic acids Human genes 0.000 claims 6
- 108020004707 nucleic acids Proteins 0.000 claims 6
- 150000007523 nucleic acids Chemical class 0.000 claims 6
- 102000005962 receptors Human genes 0.000 claims 6
- 108020003175 receptors Proteins 0.000 claims 6
- 230000008685 targeting Effects 0.000 claims 6
- 102100032768 Complement receptor type 2 Human genes 0.000 claims 5
- 101000623901 Homo sapiens Mucin-16 Proteins 0.000 claims 5
- 102000003735 Mesothelin Human genes 0.000 claims 5
- 108090000015 Mesothelin Proteins 0.000 claims 5
- 102100023123 Mucin-16 Human genes 0.000 claims 5
- 102100032780 Semaphorin-5B Human genes 0.000 claims 5
- 210000003719 b-lymphocyte Anatomy 0.000 claims 5
- 201000011510 cancer Diseases 0.000 claims 5
- 210000002865 immune cell Anatomy 0.000 claims 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 108010023729 Complement 3d Receptors Proteins 0.000 claims 4
- 101000654679 Homo sapiens Semaphorin-5B Proteins 0.000 claims 4
- 101000835745 Homo sapiens Teratocarcinoma-derived growth factor 1 Proteins 0.000 claims 4
- 108060003951 Immunoglobulin Proteins 0.000 claims 4
- 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 claims 4
- 102100026404 Teratocarcinoma-derived growth factor 1 Human genes 0.000 claims 4
- 125000000539 amino acid group Chemical group 0.000 claims 4
- 239000000427 antigen Substances 0.000 claims 4
- 108091007433 antigens Proteins 0.000 claims 4
- 102000036639 antigens Human genes 0.000 claims 4
- 239000013604 expression vector Substances 0.000 claims 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims 4
- 102000018358 immunoglobulin Human genes 0.000 claims 4
- 238000012737 microarray-based gene expression Methods 0.000 claims 4
- 238000012243 multiplex automated genomic engineering Methods 0.000 claims 4
- 102100025218 B-cell differentiation antigen CD72 Human genes 0.000 claims 3
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims 3
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims 3
- 102100024220 CD180 antigen Human genes 0.000 claims 3
- 102100038078 CD276 antigen Human genes 0.000 claims 3
- 101710185679 CD276 antigen Proteins 0.000 claims 3
- 101150013553 CD40 gene Proteins 0.000 claims 3
- 108010021064 CTLA-4 Antigen Proteins 0.000 claims 3
- 229940045513 CTLA4 antagonist Drugs 0.000 claims 3
- 201000009030 Carcinoma Diseases 0.000 claims 3
- 102000011412 Complement 3d Receptors Human genes 0.000 claims 3
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims 3
- 102100031511 Fc receptor-like protein 2 Human genes 0.000 claims 3
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims 3
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims 3
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims 3
- 101000980829 Homo sapiens CD180 antigen Proteins 0.000 claims 3
- 101000941929 Homo sapiens Complement receptor type 2 Proteins 0.000 claims 3
- 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims 3
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 claims 3
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 claims 3
- 101000777628 Homo sapiens Leukocyte antigen CD37 Proteins 0.000 claims 3
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims 3
- 101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 claims 3
- 101001136592 Homo sapiens Prostate stem cell antigen Proteins 0.000 claims 3
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims 3
- 101000844504 Homo sapiens Transient receptor potential cation channel subfamily M member 4 Proteins 0.000 claims 3
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims 3
- 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 claims 3
- 102000010787 Interleukin-4 Receptors Human genes 0.000 claims 3
- 108010038486 Interleukin-4 Receptors Proteins 0.000 claims 3
- 102100031586 Leukocyte antigen CD37 Human genes 0.000 claims 3
- 108010052285 Membrane Proteins Proteins 0.000 claims 3
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims 3
- 239000002202 Polyethylene glycol Substances 0.000 claims 3
- 102100036735 Prostate stem cell antigen Human genes 0.000 claims 3
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims 3
- 210000001744 T-lymphocyte Anatomy 0.000 claims 3
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims 3
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims 3
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims 3
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims 3
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 229920001223 polyethylene glycol Polymers 0.000 claims 3
- 210000002307 prostate Anatomy 0.000 claims 3
- 238000006467 substitution reaction Methods 0.000 claims 3
- 230000005945 translocation Effects 0.000 claims 3
- 102100023990 60S ribosomal protein L17 Human genes 0.000 claims 2
- 208000031261 Acute myeloid leukaemia Diseases 0.000 claims 2
- 108091008875 B cell receptors Proteins 0.000 claims 2
- 101710129514 B-cell differentiation antigen CD72 Proteins 0.000 claims 2
- 108010074708 B7-H1 Antigen Proteins 0.000 claims 2
- 102100031658 C-X-C chemokine receptor type 5 Human genes 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 claims 2
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 claims 2
- 101000846911 Homo sapiens Fc receptor-like protein 2 Proteins 0.000 claims 2
- 101001103039 Homo sapiens Inactive tyrosine-protein kinase transmembrane receptor ROR1 Proteins 0.000 claims 2
- 101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 claims 2
- 101001106413 Homo sapiens Macrophage-stimulating protein receptor Proteins 0.000 claims 2
- 101000934372 Homo sapiens Macrosialin Proteins 0.000 claims 2
- 101000798702 Homo sapiens Transmembrane protease serine 4 Proteins 0.000 claims 2
- 101000830603 Homo sapiens Tumor necrosis factor ligand superfamily member 11 Proteins 0.000 claims 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 2
- 102100039615 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Human genes 0.000 claims 2
- 108010002350 Interleukin-2 Proteins 0.000 claims 2
- 102100020873 Interleukin-2 Human genes 0.000 claims 2
- 102100033493 Interleukin-3 receptor subunit alpha Human genes 0.000 claims 2
- 108090000862 Ion Channels Proteins 0.000 claims 2
- 102000004310 Ion Channels Human genes 0.000 claims 2
- 102000052922 Large Neutral Amino Acid-Transporter 1 Human genes 0.000 claims 2
- 108010006444 Leucine-Rich Repeat Proteins Proteins 0.000 claims 2
- 206010025323 Lymphomas Diseases 0.000 claims 2
- 102100021435 Macrophage-stimulating protein receptor Human genes 0.000 claims 2
- 102100025136 Macrosialin Human genes 0.000 claims 2
- 102000018697 Membrane Proteins Human genes 0.000 claims 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims 2
- 102100037603 P2X purinoceptor 5 Human genes 0.000 claims 2
- 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 claims 2
- 101710089372 Programmed cell death protein 1 Proteins 0.000 claims 2
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 2
- 102100029986 Receptor tyrosine-protein kinase erbB-3 Human genes 0.000 claims 2
- 101710100969 Receptor tyrosine-protein kinase erbB-3 Proteins 0.000 claims 2
- 108091006232 SLC7A5 Proteins 0.000 claims 2
- 102100038437 Sodium-dependent phosphate transport protein 2B Human genes 0.000 claims 2
- 101150117918 Tacstd2 gene Proteins 0.000 claims 2
- 102100031228 Transient receptor potential cation channel subfamily M member 4 Human genes 0.000 claims 2
- 102100032471 Transmembrane protease serine 4 Human genes 0.000 claims 2
- 102100024568 Tumor necrosis factor ligand superfamily member 11 Human genes 0.000 claims 2
- 102100027212 Tumor-associated calcium signal transducer 2 Human genes 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 2
- 210000004443 dendritic cell Anatomy 0.000 claims 2
- 238000013461 design Methods 0.000 claims 2
- 230000004069 differentiation Effects 0.000 claims 2
- 108010087914 epidermal growth factor receptor VIII Proteins 0.000 claims 2
- 210000002950 fibroblast Anatomy 0.000 claims 2
- 229960000304 folic acid Drugs 0.000 claims 2
- 235000019152 folic acid Nutrition 0.000 claims 2
- 239000011724 folic acid Substances 0.000 claims 2
- 210000004901 leucine-rich repeat Anatomy 0.000 claims 2
- 210000002540 macrophage Anatomy 0.000 claims 2
- 210000000822 natural killer cell Anatomy 0.000 claims 2
- 229910052708 sodium Inorganic materials 0.000 claims 2
- 239000011734 sodium Substances 0.000 claims 2
- 210000004881 tumor cell Anatomy 0.000 claims 2
- 230000002792 vascular Effects 0.000 claims 2
- BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 claims 1
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 claims 1
- WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 claims 1
- 102100040079 A-kinase anchor protein 4 Human genes 0.000 claims 1
- 101710109924 A-kinase anchor protein 4 Proteins 0.000 claims 1
- 208000030507 AIDS Diseases 0.000 claims 1
- 102100033793 ALK tyrosine kinase receptor Human genes 0.000 claims 1
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 claims 1
- 102100023635 Alpha-fetoprotein Human genes 0.000 claims 1
- 102100032187 Androgen receptor Human genes 0.000 claims 1
- 102100023003 Ankyrin repeat domain-containing protein 30A Human genes 0.000 claims 1
- 108091023037 Aptamer Proteins 0.000 claims 1
- 101100208111 Arabidopsis thaliana TRX5 gene Proteins 0.000 claims 1
- 102100024003 Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 Human genes 0.000 claims 1
- 230000024704 B cell apoptotic process Effects 0.000 claims 1
- 108010008014 B-Cell Maturation Antigen Proteins 0.000 claims 1
- 102000006942 B-Cell Maturation Antigen Human genes 0.000 claims 1
- 102100027205 B-cell antigen receptor complex-associated protein alpha chain Human genes 0.000 claims 1
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims 1
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims 1
- 230000003844 B-cell-activation Effects 0.000 claims 1
- 102100027522 Baculoviral IAP repeat-containing protein 7 Human genes 0.000 claims 1
- 108010040422 Bone Morphogenetic Protein Receptors Proteins 0.000 claims 1
- 102000001893 Bone Morphogenetic Protein Receptors Human genes 0.000 claims 1
- 102100027052 Bone morphogenetic protein receptor type-1B Human genes 0.000 claims 1
- 108010085074 Brevican Proteins 0.000 claims 1
- 102100032312 Brevican core protein Human genes 0.000 claims 1
- 108010061298 CXCR5 Receptors Proteins 0.000 claims 1
- 101100314454 Caenorhabditis elegans tra-1 gene Proteins 0.000 claims 1
- 102100036369 Carbonic anhydrase 6 Human genes 0.000 claims 1
- 108010078791 Carrier Proteins Proteins 0.000 claims 1
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 108010008955 Chemokine CXCL13 Proteins 0.000 claims 1
- 102000006574 Chemokine CXCL13 Human genes 0.000 claims 1
- 101710178046 Chorismate synthase 1 Proteins 0.000 claims 1
- 102100039585 Claudin-16 Human genes 0.000 claims 1
- 102100038449 Claudin-6 Human genes 0.000 claims 1
- 102100035167 Coiled-coil domain-containing protein 54 Human genes 0.000 claims 1
- 102100030886 Complement receptor type 1 Human genes 0.000 claims 1
- 108010060385 Cyclin B1 Proteins 0.000 claims 1
- 101710152695 Cysteine synthase 1 Proteins 0.000 claims 1
- 102100027417 Cytochrome P450 1B1 Human genes 0.000 claims 1
- 102100036466 Delta-like protein 3 Human genes 0.000 claims 1
- 108700022150 Designed Ankyrin Repeat Proteins Proteins 0.000 claims 1
- 102100026245 E3 ubiquitin-protein ligase RNF43 Human genes 0.000 claims 1
- 101150049307 EEF1A2 gene Proteins 0.000 claims 1
- 101150029707 ERBB2 gene Proteins 0.000 claims 1
- 102100038083 Endosialin Human genes 0.000 claims 1
- 101710144543 Endosialin Proteins 0.000 claims 1
- 108050009340 Endothelin Proteins 0.000 claims 1
- 102000002045 Endothelin Human genes 0.000 claims 1
- 108010055196 EphA2 Receptor Proteins 0.000 claims 1
- 102100030340 Ephrin type-A receptor 2 Human genes 0.000 claims 1
- 101800003838 Epidermal growth factor Proteins 0.000 claims 1
- 102100031517 Fc receptor-like protein 1 Human genes 0.000 claims 1
- 101710120224 Fc receptor-like protein 1 Proteins 0.000 claims 1
- 102100031507 Fc receptor-like protein 5 Human genes 0.000 claims 1
- 102000003817 Fos-related antigen 1 Human genes 0.000 claims 1
- 108090000123 Fos-related antigen 1 Proteins 0.000 claims 1
- 108091006027 G proteins Proteins 0.000 claims 1
- 102100032340 G2/mitotic-specific cyclin-B1 Human genes 0.000 claims 1
- 102000030782 GTP binding Human genes 0.000 claims 1
- 108091000058 GTP-Binding Proteins 0.000 claims 1
- 101001077417 Gallus gallus Potassium voltage-gated channel subfamily H member 6 Proteins 0.000 claims 1
- 206010064571 Gene mutation Diseases 0.000 claims 1
- 208000031886 HIV Infections Diseases 0.000 claims 1
- 102100031546 HLA class II histocompatibility antigen, DO beta chain Human genes 0.000 claims 1
- 102000018713 Histocompatibility Antigens Class II Human genes 0.000 claims 1
- 108010027412 Histocompatibility Antigens Class II Proteins 0.000 claims 1
- 208000017604 Hodgkin disease Diseases 0.000 claims 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 claims 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims 1
- 101000779641 Homo sapiens ALK tyrosine kinase receptor Proteins 0.000 claims 1
- 101000757191 Homo sapiens Ankyrin repeat domain-containing protein 30A Proteins 0.000 claims 1
- 101000914489 Homo sapiens B-cell antigen receptor complex-associated protein alpha chain Proteins 0.000 claims 1
- 101000934359 Homo sapiens B-cell differentiation antigen CD72 Proteins 0.000 claims 1
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims 1
- 101000936083 Homo sapiens Baculoviral IAP repeat-containing protein 7 Proteins 0.000 claims 1
- 101000984546 Homo sapiens Bone morphogenetic protein receptor type-1B Proteins 0.000 claims 1
- 101000922405 Homo sapiens C-X-C chemokine receptor type 5 Proteins 0.000 claims 1
- 101000714525 Homo sapiens Carbonic anhydrase 6 Proteins 0.000 claims 1
- 101000888608 Homo sapiens Claudin-16 Proteins 0.000 claims 1
- 101000882898 Homo sapiens Claudin-6 Proteins 0.000 claims 1
- 101000737052 Homo sapiens Coiled-coil domain-containing protein 54 Proteins 0.000 claims 1
- 101000727061 Homo sapiens Complement receptor type 1 Proteins 0.000 claims 1
- 101000725164 Homo sapiens Cytochrome P450 1B1 Proteins 0.000 claims 1
- 101000928513 Homo sapiens Delta-like protein 3 Proteins 0.000 claims 1
- 101100119857 Homo sapiens FCRL2 gene Proteins 0.000 claims 1
- 101000846908 Homo sapiens Fc receptor-like protein 5 Proteins 0.000 claims 1
- 101000866281 Homo sapiens HLA class II histocompatibility antigen, DO beta chain Proteins 0.000 claims 1
- 101000606465 Homo sapiens Inactive tyrosine-protein kinase 7 Proteins 0.000 claims 1
- 101001002657 Homo sapiens Interleukin-2 Proteins 0.000 claims 1
- 101000868279 Homo sapiens Leukocyte surface antigen CD47 Proteins 0.000 claims 1
- 101001065568 Homo sapiens Lymphocyte antigen 6E Proteins 0.000 claims 1
- 101000578784 Homo sapiens Melanoma antigen recognized by T-cells 1 Proteins 0.000 claims 1
- 101000628547 Homo sapiens Metalloreductase STEAP1 Proteins 0.000 claims 1
- 101001133056 Homo sapiens Mucin-1 Proteins 0.000 claims 1
- 101000623905 Homo sapiens Mucin-15 Proteins 0.000 claims 1
- 101001024605 Homo sapiens Next to BRCA1 gene 1 protein Proteins 0.000 claims 1
- 101000613490 Homo sapiens Paired box protein Pax-3 Proteins 0.000 claims 1
- 101000601724 Homo sapiens Paired box protein Pax-5 Proteins 0.000 claims 1
- 101001136981 Homo sapiens Proteasome subunit beta type-9 Proteins 0.000 claims 1
- 101000880770 Homo sapiens Protein SSX2 Proteins 0.000 claims 1
- 101001130286 Homo sapiens Rab GTPase-binding effector protein 2 Proteins 0.000 claims 1
- 101000831949 Homo sapiens Receptor for retinol uptake STRA6 Proteins 0.000 claims 1
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims 1
- 101001094545 Homo sapiens Retrotransposon-like protein 1 Proteins 0.000 claims 1
- 101100420560 Homo sapiens SLC39A6 gene Proteins 0.000 claims 1
- 101000604039 Homo sapiens Sodium-dependent phosphate transport protein 2B Proteins 0.000 claims 1
- 101000824971 Homo sapiens Sperm surface protein Sp17 Proteins 0.000 claims 1
- 101000873927 Homo sapiens Squamous cell carcinoma antigen recognized by T-cells 3 Proteins 0.000 claims 1
- 101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 claims 1
- 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 claims 1
- 101001010792 Homo sapiens Transcriptional regulator ERG Proteins 0.000 claims 1
- 101000798700 Homo sapiens Transmembrane protease serine 3 Proteins 0.000 claims 1
- 101000798548 Homo sapiens Transmembrane protein 238 Proteins 0.000 claims 1
- 101001103033 Homo sapiens Tyrosine-protein kinase transmembrane receptor ROR2 Proteins 0.000 claims 1
- 101000808114 Homo sapiens Uroplakin-1b Proteins 0.000 claims 1
- 101000955999 Homo sapiens V-set domain-containing T-cell activation inhibitor 1 Proteins 0.000 claims 1
- 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 claims 1
- 101000814512 Homo sapiens X antigen family member 1 Proteins 0.000 claims 1
- 101710123134 Ice-binding protein Proteins 0.000 claims 1
- 101710082837 Ice-structuring protein Proteins 0.000 claims 1
- 102100039813 Inactive tyrosine-protein kinase 7 Human genes 0.000 claims 1
- 102100031413 L-dopachrome tautomerase Human genes 0.000 claims 1
- 101710093778 L-dopachrome tautomerase Proteins 0.000 claims 1
- 102100032913 Leukocyte surface antigen CD47 Human genes 0.000 claims 1
- 102100032131 Lymphocyte antigen 6E Human genes 0.000 claims 1
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 claims 1
- 108700012912 MYCN Proteins 0.000 claims 1
- 101150022024 MYCN gene Proteins 0.000 claims 1
- 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 claims 1
- 108010006035 Metalloproteases Proteins 0.000 claims 1
- 102000005741 Metalloproteases Human genes 0.000 claims 1
- 102100026712 Metalloreductase STEAP1 Human genes 0.000 claims 1
- 208000032818 Microsatellite Instability Diseases 0.000 claims 1
- 102100034256 Mucin-1 Human genes 0.000 claims 1
- 102100023128 Mucin-15 Human genes 0.000 claims 1
- 208000034578 Multiple myelomas Diseases 0.000 claims 1
- 101000623899 Mus musculus Mucin-13 Proteins 0.000 claims 1
- 101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 claims 1
- 101100042271 Mus musculus Sema3b gene Proteins 0.000 claims 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 claims 1
- 102000055056 N-Myc Proto-Oncogene Human genes 0.000 claims 1
- 108700026495 N-Myc Proto-Oncogene Proteins 0.000 claims 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims 1
- 102000015636 Oligopeptides Human genes 0.000 claims 1
- 108010038807 Oligopeptides Proteins 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 101710189969 P2X purinoceptor 5 Proteins 0.000 claims 1
- 102100040891 Paired box protein Pax-3 Human genes 0.000 claims 1
- 102100037504 Paired box protein Pax-5 Human genes 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 108010092528 Phosphate Transport Proteins Proteins 0.000 claims 1
- 102000016462 Phosphate Transport Proteins Human genes 0.000 claims 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 102100022807 Potassium voltage-gated channel subfamily H member 2 Human genes 0.000 claims 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 1
- 102100033237 Pro-epidermal growth factor Human genes 0.000 claims 1
- 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 claims 1
- 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 claims 1
- 102100035764 Proteasome subunit beta type-9 Human genes 0.000 claims 1
- 102100032831 Protein ITPRID2 Human genes 0.000 claims 1
- 102100037686 Protein SSX2 Human genes 0.000 claims 1
- 108010080192 Purinergic Receptors Proteins 0.000 claims 1
- 102100031524 Rab GTPase-binding effector protein 2 Human genes 0.000 claims 1
- 102100024235 Receptor for retinol uptake STRA6 Human genes 0.000 claims 1
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims 1
- 102100037421 Regulator of G-protein signaling 5 Human genes 0.000 claims 1
- 101710140403 Regulator of G-protein signaling 5 Proteins 0.000 claims 1
- 208000006265 Renal cell carcinoma Diseases 0.000 claims 1
- 102000014400 SH2 domains Human genes 0.000 claims 1
- 108050003452 SH2 domains Proteins 0.000 claims 1
- 108091006576 SLC34A2 Proteins 0.000 claims 1
- 108010029477 STAT5 Transcription Factor Proteins 0.000 claims 1
- 206010039491 Sarcoma Diseases 0.000 claims 1
- 102000009203 Sema domains Human genes 0.000 claims 1
- 108050000099 Sema domains Proteins 0.000 claims 1
- 108050003978 Semaphorin Proteins 0.000 claims 1
- 102000014105 Semaphorin Human genes 0.000 claims 1
- 101710199399 Semaphorin-5B Proteins 0.000 claims 1
- 101710173694 Short transient receptor potential channel 2 Proteins 0.000 claims 1
- 102100024481 Signal transducer and activator of transcription 5A Human genes 0.000 claims 1
- 206010041067 Small cell lung cancer Diseases 0.000 claims 1
- 102100035748 Squamous cell carcinoma antigen recognized by T-cells 3 Human genes 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- 108010002687 Survivin Proteins 0.000 claims 1
- 102000000763 Survivin Human genes 0.000 claims 1
- 206010042674 Swelling Diseases 0.000 claims 1
- 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 claims 1
- 102000003618 TRPM4 Human genes 0.000 claims 1
- 206010043276 Teratoma Diseases 0.000 claims 1
- 102000002938 Thrombospondin Human genes 0.000 claims 1
- 108060008245 Thrombospondin Proteins 0.000 claims 1
- 102100032476 Transmembrane protein 238 Human genes 0.000 claims 1
- 102100029690 Tumor necrosis factor receptor superfamily member 13C Human genes 0.000 claims 1
- 101710178300 Tumor necrosis factor receptor superfamily member 13C Proteins 0.000 claims 1
- 101710107540 Type-2 ice-structuring protein Proteins 0.000 claims 1
- 102100039616 Tyrosine-protein kinase transmembrane receptor ROR2 Human genes 0.000 claims 1
- 102100038853 Uroplakin-1b Human genes 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- 102100038929 V-set domain-containing T-cell activation inhibitor 1 Human genes 0.000 claims 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 1
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 102100039490 X antigen family member 1 Human genes 0.000 claims 1
- 102100023144 Zinc transporter ZIP6 Human genes 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 108010080146 androgen receptors Proteins 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 125000002619 bicyclic group Chemical group 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 210000001185 bone marrow Anatomy 0.000 claims 1
- 210000004899 c-terminal region Anatomy 0.000 claims 1
- 230000011712 cell development Effects 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000000470 constituent Substances 0.000 claims 1
- 210000000805 cytoplasm Anatomy 0.000 claims 1
- 230000007547 defect Effects 0.000 claims 1
- 230000007123 defense Effects 0.000 claims 1
- 229940127276 delta-like ligand 3 Drugs 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 230000003831 deregulation Effects 0.000 claims 1
- 238000011161 development Methods 0.000 claims 1
- 230000018109 developmental process Effects 0.000 claims 1
- 238000002405 diagnostic procedure Methods 0.000 claims 1
- 230000009266 disease activity Effects 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 claims 1
- 239000003623 enhancer Substances 0.000 claims 1
- 229940116977 epidermal growth factor Drugs 0.000 claims 1
- 230000001605 fetal effect Effects 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 125000002446 fucosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)[C@@H](O1)C)* 0.000 claims 1
- 230000004927 fusion Effects 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 125000003827 glycol group Chemical group 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 claims 1
- 238000009169 immunotherapy Methods 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 210000003593 megakaryocyte Anatomy 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000005012 migration Effects 0.000 claims 1
- 238000013508 migration Methods 0.000 claims 1
- 230000003278 mimic effect Effects 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 230000004766 neurogenesis Effects 0.000 claims 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 230000007310 pathophysiology Effects 0.000 claims 1
- 230000026731 phosphorylation Effects 0.000 claims 1
- 238000006366 phosphorylation reaction Methods 0.000 claims 1
- 108040000983 polyphosphate:AMP phosphotransferase activity proteins Proteins 0.000 claims 1
- 210000003289 regulatory T cell Anatomy 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 208000000587 small cell lung carcinoma Diseases 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
- 229910000162 sodium phosphate Inorganic materials 0.000 claims 1
- 239000001488 sodium phosphate Substances 0.000 claims 1
- 210000004085 squamous epithelial cell Anatomy 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
- 101150050955 stn gene Proteins 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 230000008961 swelling Effects 0.000 claims 1
- 230000005062 synaptic transmission Effects 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
- 101150047061 tag-72 gene Proteins 0.000 claims 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 1
- 230000002485 urinary effect Effects 0.000 claims 1
- 210000001635 urinary tract Anatomy 0.000 claims 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024007979A JP7741903B2 (ja) | 2018-06-25 | 2024-01-23 | 強力で選択的なインターロイキン模倣体のデノボ設計 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862689769P | 2018-06-25 | 2018-06-25 | |
| US62/689,769 | 2018-06-25 | ||
| US201862768733P | 2018-11-16 | 2018-11-16 | |
| US62/768,733 | 2018-11-16 | ||
| PCT/US2019/038703 WO2020005819A1 (en) | 2018-06-25 | 2019-06-24 | De novo design of potent and selective interleukin mimetics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024007979A Division JP7741903B2 (ja) | 2018-06-25 | 2024-01-23 | 強力で選択的なインターロイキン模倣体のデノボ設計 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021528052A JP2021528052A (ja) | 2021-10-21 |
| JPWO2020005819A5 true JPWO2020005819A5 (enExample) | 2024-01-31 |
Family
ID=67352582
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020567827A Pending JP2021528052A (ja) | 2018-06-25 | 2019-06-24 | 強力で選択的なインターロイキン模倣体のデノボ設計 |
| JP2024007979A Active JP7741903B2 (ja) | 2018-06-25 | 2024-01-23 | 強力で選択的なインターロイキン模倣体のデノボ設計 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024007979A Active JP7741903B2 (ja) | 2018-06-25 | 2024-01-23 | 強力で選択的なインターロイキン模倣体のデノボ設計 |
Country Status (13)
| Country | Link |
|---|---|
| US (8) | US10703791B2 (enExample) |
| EP (1) | EP3810640A1 (enExample) |
| JP (2) | JP2021528052A (enExample) |
| KR (1) | KR20210025522A (enExample) |
| CN (1) | CN112739713A (enExample) |
| AU (1) | AU2019295637B2 (enExample) |
| BR (1) | BR112020025287A2 (enExample) |
| CA (1) | CA3102653A1 (enExample) |
| IL (1) | IL279415A (enExample) |
| MX (1) | MX2020014027A (enExample) |
| PH (1) | PH12020552140A1 (enExample) |
| SG (1) | SG11202011460YA (enExample) |
| WO (1) | WO2020005819A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019139987A1 (en) | 2018-01-09 | 2019-07-18 | Elstar Therapeutics, Inc. | Calreticulin binding constructs and engineered t cells for the treatment of diseases |
| WO2019178362A1 (en) | 2018-03-14 | 2019-09-19 | Elstar Therapeutics, Inc. | Multifunctional molecules that bind to calreticulin and uses thereof |
| SG11202011460YA (en) | 2018-06-25 | 2020-12-30 | Univ Washington | De novo design of potent and selective interleukin mimetics |
| AU2019297451A1 (en) | 2018-07-03 | 2021-01-28 | Marengo Therapeutics, Inc. | Anti-TCR antibody molecules and uses thereof |
| US12234572B2 (en) * | 2018-11-20 | 2025-02-25 | University Of Washington | Split interleukin mimetics and their use |
| AU2020224681A1 (en) | 2019-02-21 | 2021-09-16 | Marengo Therapeutics, Inc. | Antibody molecules that bind to NKp30 and uses thereof |
| GB2599228B (en) | 2019-02-21 | 2024-02-07 | Marengo Therapeutics Inc | Multifunctional molecules that bind to T cell related cancer cells and uses thereof |
| US20220370563A1 (en) * | 2019-10-25 | 2022-11-24 | Neoleukin Therapeutics, Inc. | Methods of administration of il-2 receptor agonists |
| US20210188934A1 (en) | 2019-12-20 | 2021-06-24 | Regeneron Pharmaceuticals, Inc. | Novel il2 agonists and methods of use thereof |
| JP2023509708A (ja) | 2020-01-03 | 2023-03-09 | マレンゴ・セラピューティクス，インコーポレーテッド | 抗ｔｃｒ抗体分子およびその使用 |
| WO2021188374A2 (en) * | 2020-03-16 | 2021-09-23 | Neoleukin Therapeutics, Inc. | Interleukin-2 receptor βeta (il-2rβ) binding polypeptides |
| CN114380919B (zh) * | 2020-10-18 | 2024-06-25 | 北京志道生物科技有限公司 | 经修饰的il-2分子及其用途 |
| CN112266413A (zh) * | 2020-10-22 | 2021-01-26 | 中国人民解放军海军军医大学 | 扩增nk细胞并增强其杀伤活性的因子、饲养细胞系及方法 |
| WO2022200525A1 (en) | 2021-03-26 | 2022-09-29 | Innate Pharma | Multispecific proteins comprising an nkp46-binding site, a cancer antgienge binding site fused to a cytokine for nk cell engaging |
| CN117616050A (zh) | 2021-06-09 | 2024-02-27 | 先天制药公司 | 与nkp46、细胞因子受体、肿瘤抗原和cd16a结合的多特异性蛋白质 |
| WO2022258691A1 (en) | 2021-06-09 | 2022-12-15 | Innate Pharma | Multispecific proteins binding to nkg2d, a cytokine receptor, a tumour antigen and cd16a |
| WO2022258678A1 (en) | 2021-06-09 | 2022-12-15 | Innate Pharma | Multispecific proteins binding to nkp30, a cytokine receptor, a tumour antigen and cd16a |
| CN113603791A (zh) * | 2021-08-11 | 2021-11-05 | 厦门目青股权投资合伙企业(有限合伙) | 一种融合蛋白及其应用 |
| WO2023044318A2 (en) * | 2021-09-15 | 2023-03-23 | Neoleukin Therapeutics, Inc. | Interleukin-2 receptor βeta (il-2rβ) binding polypeptides |
| WO2023052541A1 (en) * | 2021-09-30 | 2023-04-06 | Imcheck Therapeutics | Combination of an anti-btn3a activating antibody and an il-2 agonist for use in therapy |
| MX2024008642A (es) * | 2022-01-11 | 2024-09-23 | Outpace Bio Inc | Composiciones de citocinas dise?adas y metodos de uso. |
| WO2023150733A2 (en) * | 2022-02-04 | 2023-08-10 | The Board Of Trustees Of The Leland Stanford Junior University | Surrogate cytokine polypeptides |
| CN114333985B (zh) * | 2022-03-03 | 2022-07-12 | 北京晶泰科技有限公司 | 环肽设计方法、复合物结构的生成方法、装置及电子设备 |
| CN115124627A (zh) * | 2022-06-20 | 2022-09-30 | 中国人民解放军海军军医大学 | 一种自分泌IL2Rβγ激动剂的MSLN-CAR-NK细胞及其应用 |
| CN114773433B (zh) * | 2022-06-23 | 2022-09-06 | 北京肿瘤医院(北京大学肿瘤医院) | 一种cd25靶向多肽、分子探针及应用 |
| AU2023298151A1 (en) * | 2022-07-01 | 2025-01-02 | Neurogene Inc. | Neo-2/15 variants and uses thereof for preferentially stimulating t-regulatory cells |
| WO2024177972A2 (en) * | 2023-02-20 | 2024-08-29 | The Wistar Institute Of Anatomy And Biology | Antibody-cytokine chimeras |
| WO2024240233A1 (zh) * | 2023-05-24 | 2024-11-28 | 南通壹宸生物医药科技有限公司 | 多肽及其偶联物和应用 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5229109A (en) | 1992-04-14 | 1993-07-20 | Board Of Regents, The University Of Texas System | Low toxicity interleukin-2 analogues for use in immunotherapy |
| US6955807B1 (en) | 1998-05-15 | 2005-10-18 | Bayer Pharmaceuticals Corporation | IL-2 selective agonists and antagonists |
| US6168785B1 (en) | 1998-07-16 | 2001-01-02 | Institut Pasteur | Biological applications of new peptides of IL-2 and derivatives and use as therapeutic agents |
| JP2003520579A (ja) | 1999-12-08 | 2003-07-08 | アムジェン インコーポレイテッド | インターフェロン様分子およびその使用 |
| GB0019638D0 (en) * | 2000-08-09 | 2000-09-27 | European Molecular Biology Lab Embl | Peptide mimetics |
| CA2450147A1 (en) * | 2001-06-07 | 2002-12-19 | Wyeth | Solution structure of il-13 and uses thereof |
| BRPI0412668A (pt) * | 2003-08-07 | 2006-09-26 | Hoffmann La Roche | peptìdeos antigênicos de ar |
| CN1930300A (zh) | 2004-03-05 | 2007-03-14 | 希龙公司 | 预测患者治疗药物耐受性的体外试验系统 |
| BRPI0617688A2 (pt) * | 2005-10-21 | 2011-06-07 | Hoffmann La Roche | método para expressão recombinante de um polipeptìdeo |
| US9676871B2 (en) | 2010-11-05 | 2017-06-13 | Pfizer Inc. | Engineered polypeptide conjugates and methods for making thereof using transglutaminase |
| CA2860170C (en) | 2010-12-22 | 2022-06-14 | The Board Of Trustees Of The Leland Stanford Junior University | Superagonists and antagonists of interleukin-2 |
| WO2013177187A2 (en) | 2012-05-22 | 2013-11-28 | Massachusetts Institute Of Technology | Synergistic tumor treatment with extended-pk il-2 and therapeutic agents |
| US20170350886A1 (en) * | 2014-02-28 | 2017-12-07 | Glenmark Pharmaceuticals S.A. | Expression constructs and methods for selecting host cells expressing polypeptides |
| WO2015164815A1 (en) | 2014-04-24 | 2015-10-29 | The Board Of Trustees Of The Leland Stanford Junior University | Superagonists, partial agonists and antagonists of interleukin-2 |
| SG11201608953WA (en) | 2014-04-30 | 2016-11-29 | Pfizer | Anti-ptk7 antibody-drug conjugates |
| CN113234138A (zh) | 2014-08-11 | 2021-08-10 | 德里尼亚公司 | 选择性地活化调节性t细胞用于治疗自身免疫病的修饰的il-2变体 |
| AR105616A1 (es) | 2015-05-07 | 2017-10-25 | Lilly Co Eli | Proteínas de fusión |
| EP3585806A1 (en) | 2017-02-24 | 2020-01-01 | Philogen S.p.A. | Immunoconjugates with optimized linkers and orientation |
| JP2020514419A (ja) | 2017-03-15 | 2020-05-21 | シルバーバック セラピューティックス インコーポレイテッド | ベンズアゼピン化合物、そのコンジュゲート及び使用 |
| SG11202011460YA (en) * | 2018-06-25 | 2020-12-30 | Univ Washington | De novo design of potent and selective interleukin mimetics |
| US12234572B2 (en) * | 2018-11-20 | 2025-02-25 | University Of Washington | Split interleukin mimetics and their use |
| AU2019384145A1 (en) * | 2018-11-20 | 2021-06-10 | Innovative Cellular Therapeutics Holdings, Ltd. | Modified cell expressing therapeutic agent and uses thereof |
| US20220370563A1 (en) | 2019-10-25 | 2022-11-24 | Neoleukin Therapeutics, Inc. | Methods of administration of il-2 receptor agonists |
| CA3161364A1 (en) | 2019-12-24 | 2021-07-01 | Carl WALKEY | Combination therapy using an il-2 receptor agonist and an immune checkpoint inhibitor |
| CN111040981A (zh) * | 2019-12-26 | 2020-04-21 | 南昌大学 | 表达重组IL-2的重组大肠杆菌Nissle 1917及其功能验证方法 |
| WO2021188374A2 (en) | 2020-03-16 | 2021-09-23 | Neoleukin Therapeutics, Inc. | Interleukin-2 receptor βeta (il-2rβ) binding polypeptides |
-
2019
- 2019-06-24 SG SG11202011460YA patent/SG11202011460YA/en unknown
- 2019-06-24 CN CN201980042036.7A patent/CN112739713A/zh active Pending
- 2019-06-24 BR BR112020025287-5A patent/BR112020025287A2/pt unknown
- 2019-06-24 KR KR1020207035974A patent/KR20210025522A/ko active Pending
- 2019-06-24 WO PCT/US2019/038703 patent/WO2020005819A1/en not_active Ceased
- 2019-06-24 CA CA3102653A patent/CA3102653A1/en active Pending
- 2019-06-24 JP JP2020567827A patent/JP2021528052A/ja active Pending
- 2019-06-24 EP EP19742110.0A patent/EP3810640A1/en active Pending
- 2019-06-24 AU AU2019295637A patent/AU2019295637B2/en active Active
- 2019-06-24 MX MX2020014027A patent/MX2020014027A/es unknown
- 2019-09-16 US US16/572,038 patent/US10703791B2/en active Active
-
2020
- 2020-06-18 US US16/905,669 patent/US11117944B2/en active Active
- 2020-06-23 US US16/909,185 patent/US10844105B2/en active Active
- 2020-06-23 US US16/909,210 patent/US11401313B2/en active Active
- 2020-12-11 PH PH12020552140A patent/PH12020552140A1/en unknown
- 2020-12-13 IL IL279415A patent/IL279415A/en unknown
-
2021
- 2021-09-13 US US17/473,731 patent/US11655278B2/en active Active
-
2022
- 2022-03-18 US US17/698,553 patent/US12240880B2/en active Active
-
2023
- 2023-03-21 US US18/187,639 patent/US12227553B2/en active Active
-
2024
- 2024-01-23 JP JP2024007979A patent/JP7741903B2/ja active Active
-
2025
- 2025-01-16 US US19/025,380 patent/US20250171514A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020005819A5 (enExample) | ||
| JP2024056715A5 (enExample) | ||
| US20250270279A1 (en) | Polypeptide useful in adoptive cell therapy | |
| JP7291196B2 (ja) | 抗ヒトパピローマウイルス１６ ｅ７ ｔ細胞受容体 | |
| RU2012123007A (ru) | Конъюгаты меченных радиоактивным цирконием сконструированных антител с цистеиновыми заменами | |
| AU2020363138B2 (en) | T cell receptor recognising KRAS mutation and encoding sequence thereof | |
| JP3860398B2 (ja) | サイトカインの免疫複合体 | |
| JP2008521920A5 (enExample) | ||
| Diebold et al. | MHC class II presentation of endogenously expressed antigens by transfected dendritic cells | |
| AU728794B2 (en) | Recombinant constructs encoding T cell receptors specific for human HLA-restricted tumor antigens | |
| EP3438123A1 (en) | Chimeric cytokine receptor | |
| Weichselbaum et al. | Gene therapy of cancer | |
| US20220289820A1 (en) | Chimeric cytokine receptor | |
| JP2013544253A5 (enExample) | ||
| RU2006147264A (ru) | Коньюгаты антитело-лекарственное средство и способы | |
| CA3119472A1 (en) | Split interleukin mimetics and their use | |
| JP2016510806A5 (enExample) | ||
| Pameijer et al. | Conversion of a tumor-binding peptide identified by phage display to a functional chimeric T cell antigen receptor | |
| JP2018537076A (ja) | プログラム可能な普遍的細胞受容体およびその使用法 | |
| JP2019527673A5 (enExample) | ||
| Najjar et al. | Imaging of sleeping beauty-modified CD19-specific T cells expressing HSV1-thymidine kinase by positron emission tomography | |
| Gerson et al. | Gene therapy of cancer: translational approaches from preclinical studies to clinical implementation | |
| CN110423757A (zh) | 一种工程化核酸、t细胞及其应用和产生方法 | |
| Ma et al. | Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins | |
| JP7265788B2 (ja) | 修飾ミクロシスチンおよびノジュラリン |